A Space for Teens with Cancer

Video

Teen Cancer America partners with hospitals throughout the United States to develop specialized facilities and services for teens and young adults with cancer. We build teen friendly environments, develop standards for age-targeted care, improve collaboration between pediatric and adult specialists, and support dedicated research to improve outcomes and survival rates.

Recent Videos
a woman sitting in front of a green wall with a white top and glasses
a woman sitting in front of a CURE Background with a black and floral top
a woman with a white shirt and glasses sitting in front of a green wall.
Related Content
dark blue background with a white outline indicating layers of skin

Cemiplimab as Adjuvant Therapy Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma

Caroline Seymour
January 20th 2025
Article

Adjuvant cemiplimab demonstrated a statistically significant improvement in DFS compared to placebo in post-surgical patients with high-risk CSCC, impacting post-operative care considerations.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

a person's hand on someone's shoulder

Association Between ICDs and Aggressive End-of-Life Care in Advanced Cancer

Roman Fabbricatore
January 19th 2025
Article

Device programming encounters near the end of life occurred in nearly half of patients with ICDs, offering a potential opportunity for goals-of-care discussions.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

green background with blue text indicating FDA and dark green text saying approved with a check mark

FDA Approves Datopotamab Deruxtecan for Advanced Breast Cancer

Darlene Dobkowski, MA
January 17th 2025
Article

Datopotamab deruxtecan-dlnk received approval from the FDA for previously treated unresectable or metastatic, HR-positive, HER2-negative breast cancer.

yellow background with a white outline indicating a liver

Adding Lenvatinib/Pembrolizumab to TACE Extends PFS in Unresectable Liver Cancer

Russ Conroy
January 17th 2025
Article

The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to confirm this finding.